Belvedere Trading’s Inogen INGN Stock Holding History

Belvedere Trading’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,715	Closed	-$229K	–	805
2023 Q4	$229K	Buy	+41,715	New	+$220K	﹤0.01%	310

Other funds holding INGN

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Belvedere Trading's INGN Position: Q1 2024 in Review

Belvedere Trading sold out of Inogen (INGN) in Q1 2024, closing a stake of 41,715 shares — an estimated $229K sold.

Belvedere Trading first reported a position in INGN in Q4 2023 and held it in 1 quarter. The position peaked at $229K in Q4 2023. 129 funds tracked by Wall St. Rank hold INGN as of Q1 2024.

Belvedere Trading reported no remaining Inogen position as of Q1 2024 after selling out during the quarter.
Belvedere Trading sold 41,715 Inogen shares in Q1 2024, an estimated $229K.
Belvedere Trading first reported a position in Inogen in Q4 2023 and held it in 1 quarter.
Belvedere Trading's Inogen position peaked at $229K in Q4 2023.
129 funds tracked by Wall St. Rank held Inogen as of Q1 2024.

Based on Belvedere Trading's 13F filing for Q1 2024, filed 9 May 2024.